These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1879096)

  • 1. Pharmacokinetics of newer drugs in patients with renal impairment (Part II).
    Singlas E; Fillastre JP
    Clin Pharmacokinet; 1991 May; 20(5):389-410. PubMed ID: 1879096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).
    Ogawa R; Stachnik JM; Echizen H
    Clin Pharmacokinet; 2013 Mar; 52(3):169-85. PubMed ID: 23344981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic drug interactions with ACE inhibitors.
    Shionoiri H
    Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics in heart failure. An updated review.
    Shammas FV; Dickstein K
    Clin Pharmacokinet; 1988 Aug; 15(2):94-113. PubMed ID: 3064953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of the newer ACE inhibitors. A review.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1990 Sep; 19(3):177-96. PubMed ID: 2203579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Getachew H; Tadesse Y; Shibeshi W
    BMC Nephrol; 2015 Oct; 16():158. PubMed ID: 26446847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A primer on continuous renal replacement therapy for critically ill patients.
    Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ
    Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosage of drugs in patients with kidney diseases].
    Kokot F
    Wiad Lek; 1996; 49(7-12):87-91. PubMed ID: 9245115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.
    Fabre J; Fox HM; Dayer P; Balant L
    Clin Pharmacokinet; 1980; 5(5):441-64. PubMed ID: 6105934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of anesthesia related drugs in patients with chronic kidney disease].
    Tsubokawa T
    Masui; 2013 Nov; 62(11):1293-303. PubMed ID: 24364270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiological drugs and the elderly].
    Grand A
    Ann Cardiol Angeiol (Paris); 1997; 46(7):461-8. PubMed ID: 9452781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal considerations in cardiovascular drug therapy.
    Feinfeld DA; Frishman WH
    Cardiol Clin; 1987 Nov; 5(4):675-88. PubMed ID: 3331320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of neuromuscular blocking drugs.
    Agoston S; Vandenbrom RH; Wierda JM
    Clin Pharmacokinet; 1992 Feb; 22(2):94-115. PubMed ID: 1551294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.